Galectin Therapeutics (GALT) Stock Chart & Stock Price History → A new way to collect income from stocks (From DTI) (Ad) Free GALT Stock Alerts $3.38 0.00 (0.00%) (As of 03:45 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Galectin Therapeutics Stock Price Performance5 Day Performance+0.30%1 Month Performance+38.52%3 Month Performance+96.51%6 Month Performance+63.29%Year-To-Date Performance+103.61%1 Year Performance+83.70% Receive GALT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now GALT Stock Chart for Wednesday, April, 24, 2024 GALT Chart by TradingView Galectin Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$3.06$3.38+10.46%$3.55$2.99235,547 shs$209.22 million04/22/2024$3.37$3.06-9.20%$3.29$2.88305,524 shs$189.41 million04/19/2024$3.38$3.37-0.30%$3.47$3.20206,132 shs$208.62 million04/18/2024$3.38$3.38$3.45$3.25146,616 shs$209.22 million04/17/2024$3.40$3.38-0.59%$3.49$3.20158,985 shs$209.22 million04/16/2024$3.91$3.40-13.04%$3.87$3.32350,339 shs$210.46 million Get the Latest News and Ratings for GALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$3.97$3.91-1.51%$3.95$3.75165,954 shs$242.03 million04/12/2024$4.20$3.97-5.48%$4.27$3.75491,569 shs$245.74 million04/11/2024$3.82$4.20+9.95%$4.21$3.71403,840 shs$259.98 million04/10/2024$3.94$3.82-3.05%$4.10$3.67647,332 shs$236.46 million04/09/2024$3.74$3.94+5.35%$3.97$3.69332,158 shs$243.89 million04/08/2024$3.73$3.74+0.27%$3.75$3.40469,515 shs$231.51 million04/05/2024$3.00$3.73+24.33%$3.74$2.98929,538 shs$230.89 million04/04/2024$2.85$3.00+5.26%$3.00$2.61285,142 shs$185.70 million04/03/2024$2.51$2.85+13.55%$2.97$2.46410,355 shs$176.42 million04/02/2024$2.44$2.51+2.87%$2.60$2.37143,981 shs$155.24 million04/01/2024$2.39$2.44+2.09%$2.45$2.2666,117 shs$150.91 million03/29/2024$2.39$2.39$2.43$2.3057,692 shs$147.82 million03/28/2024$2.41$2.39-0.83%$2.43$2.3057,667 shs$147.82 million03/27/2024$2.37$2.41+1.69%$2.42$2.3582,953 shs$149.06 million03/26/2024$2.33$2.37+1.72%$2.40$2.2775,063 shs$146.58 million03/25/2024$2.44$2.33-4.51%$2.48$2.31134,904 shs$144.11 million03/22/2024$2.44$2.44$2.48$2.32155,957 shs$150.91 million03/21/2024$2.20$2.44+10.91%$2.45$2.19289,805 shs$150.91 million03/20/2024$2.10$2.20+4.76%$2.20$2.06109,387 shs$136.07 million03/19/2024$2.14$2.10-1.87%$2.18$2.0851,307 shs$129.89 million03/18/2024$2.06$2.14+3.88%$2.17$2.01150,510 shs$132.36 million03/15/2024$1.98$2.06+4.04%$2.08$1.97163,290 shs$127.41 million03/14/2024$1.98$1.98$1.98$1.9340,010 shs$122.46 million03/13/2024$1.97$1.98+0.51%$2.03$1.9334,749 shs$122.46 million03/12/2024$2.01$1.97-1.99%$2.09$1.91100,805 shs$121.84 million03/11/2024$2.04$2.01-1.47%$2.07$1.9946,689 shs$124.32 million03/08/2024$2.09$2.04-2.39%$2.10$1.9945,038 shs$126.17 million03/07/2024$2.08$2.09+0.48%$2.09$1.98106,759 shs$129.27 million03/06/2024$2.06$2.08+0.97%$2.10$2.02137,118 shs$128.65 million03/05/2024$1.99$2.06+3.52%$2.06$1.9798,466 shs$127.41 million03/04/2024$1.93$1.99+3.11%$2.02$1.9345,660 shs$123.08 million03/01/2024$1.96$1.93-1.28%$2.02$1.90123,603 shs$119.37 million02/29/2024$1.89$1.96+3.44%$2.00$1.90134,862 shs$120.92 million02/28/2024$1.86$1.89+1.61%$1.99$1.82137,553 shs$116.90 millionClaim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now02/27/2024$1.88$1.86-1.06%$1.92$1.8227,270 shs$115.04 million02/26/2024$1.88$1.88$1.91$1.8075,486 shs$116.28 million02/23/2024$1.78$1.88+5.62%$1.92$1.7990,513 shs$116.28 million02/22/2024$1.86$1.78-4.30%$1.85$1.7734,654 shs$110.09 million02/21/2024$1.86$1.86$1.89$1.7768,595 shs$115.04 million02/20/2024$1.74$1.86+6.90%$1.91$1.70124,884 shs$115.04 million02/19/2024$1.74$1.74$1.76$1.7032,600 shs$107.62 million02/16/2024$1.75$1.74-0.57%$1.76$1.7032,609 shs$107.62 million02/15/2024$1.73$1.75+1.16%$1.76$1.7441,309 shs$108.24 million02/14/2024$1.69$1.73+2.37%$1.76$1.6947,924 shs$107 million02/13/2024$1.66$1.69+1.81%$1.70$1.6324,775 shs$104.53 million02/12/2024$1.69$1.66-1.78%$1.69$1.6538,439 shs$102.67 million02/09/2024$1.63$1.69+3.68%$1.74$1.6333,139 shs$104.53 million02/08/2024$1.60$1.63+1.87%$1.65$1.6139,290 shs$100.82 million02/07/2024$1.69$1.60-5.33%$1.70$1.5940,817 shs$98.96 million02/06/2024$1.70$1.69-0.59%$1.72$1.6734,057 shs$104.53 million02/05/2024$1.76$1.70-3.41%$1.75$1.6928,369 shs$105.15 million02/02/2024$1.74$1.76+1.15%$1.76$1.6927,580 shs$108.86 million02/01/2024$1.69$1.74+2.96%$1.74$1.6741,436 shs$107.62 million01/31/2024$1.75$1.69-3.43%$1.75$1.6491,081 shs$104.53 million01/30/2024$1.78$1.75-1.69%$1.80$1.7438,620 shs$108.24 million01/29/2024$1.73$1.78+2.89%$1.80$1.7358,043 shs$110.09 million01/26/2024$1.79$1.73-3.35%$1.82$1.7138,110 shs$107 million01/25/2024$1.72$1.79+4.07%$1.81$1.7430,800 shs$110.71 million01/24/2024$1.72$1.72$1.77$1.72140,733 shs$106.38 million01/23/2024$1.75$1.72-1.71%$1.80$1.7254,481 shs$106.38 million Related Companies: SBTX Stock Price Chart ABEO Stock Price Chart DSGN Stock Price Chart GBIO Stock Price Chart GTHX Stock Price Chart ZVRA Stock Price Chart NCNA Stock Price Chart SKYE Stock Price Chart RIGL Stock Price Chart OMER Stock Price Chart Receive GALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GALT) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galectin Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.